Indications and uses
Dialyvite Supreme D is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.
Dialyvite Supreme D
- Manufacturer
- Hillestad Pharmaceuticals USA
- Effective date
- 2026-01-27
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 9
- Source
- full-release
- Hydrated at
- 2026-05-31 21:58:02
Label at a glance#
ProductDialyvite Supreme D
Active ingredientAscorbic Acid, Cholecalciferol, .alpha.-tocopherol succinate, d-, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Cobalamin, Biotin, Calcium Pantothenate, Zinc Citrate, Selenocysteine
Label structure7 sections
Dosage and administration
Take one tablet or as directed by your physician, orally.
Label contents#
Full prescribing information#
DESCRIPTION
Dialyvite Supreme D is a prescription folic acid supplement with additional nutrients for kidney dialysis patients. Dialyvite Supreme D is a small, round, light green, coated tablet, with debossed "H" on one side, and bisected on the other side.
Each tablet contains:
Folic Acid.....3 mg
Vitamin C (Ascorbic Acid).....100 mg
Vitamin D (Cholecalciferol).....2000 IU
Vitamin E (D-alpha-Tocopheryl Acid Succinate).....30 IU
Thiamine Mononitrate.....1.5 mg
Riboflavin.....1.7 mg
Niacinamide.....20 mg
Vitamin B6 (Pyridoxine HCl).....25 mg
Vitamin B12 (Methylcobalamin).....1 mg
Biotin.....300 mcg
Pantothenic Acid (Calcium Pantothenate).....10 mg
Zinc (Zinc Citrate).....15 mg
Selenium (Selenium Amino Acid Chelate).....70 mcg
Inactive ingredients:
Microcrystalline Cellulose, Croscarmellose Sodium, Mono- and Diglycerides, Pharmaceutical Glaze, Starch, Silicon Dioxide, Calcium Stearate, Chlorophyllin (color).
INDICATIONS AND USAGE
Dialyvite Supreme D is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients.
CONTRAINDICATIONS
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
PRECAUTIONS
Folic acid supplementation may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations progress.
Keep out of reach of children.
ADVERSE REACTIONS
Allergic sensitizations have been reported following oral administration of folic acid.
Consult your physician immediately if adverse side effects occur.
DOSAGE AND ADMINISTRATION
Take one tablet or as directed by your physician, orally.
PRINCIPAL DISPLAY PANEL
NDC 10542-009-09
Dialyvite Supreme D
Multivitamin Supplement for Dialysis Patients
90 Tablets
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0105420090904 | GTIN-13: 0105420090904 EAN-13: 0105420090904 GTIN-12: 105420090904 UPC-A: 105420090904 GTIN storage (14 digits): 00105420090904 | LabelHP09(rev.7).jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f47a510b-6679-4664-b2d6-47b5c4afe7cc | Product name | 4 | 20260217 |
| 86fffa7b-d382-4771-a253-25cccb64b590 | Product name | 3 | 20251124 |
| cf050ccd-1144-f76a-e00d-e5698d8597d4 | Product name | 6 | 20250625 |
| 030ce964-9b2d-45aa-b5d3-f78ce03ef61c | Product name | 2 | 20250515 |
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| 0306390c-dd77-4363-afe0-63c58088b2a1 | Product name | 1 | 20220120 |
| 503ea967-4b9c-48cf-9e87-c7975295849d | Product name | 2 | 20220120 |
| 91c62db0-0295-c81c-d10a-0856c259edd6 | Product name | 2 | 20200428 |
| d32bc2b8-0bb7-2216-87aa-24639646e202 | Product name | 3 | 20190619 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
| 190f2a5b-bbc8-65c7-fcb0-97891307b917 | Product name | 1 | 20140508 |
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10542-009-02 | Dialyvite Supreme D | 7 in 1 BOTTLE, PLASTIC | TABLET, COATED | 7 | 9 | |
| 10542-009-09 | Dialyvite Supreme D | 90 in 1 BOTTLE, PLASTIC | TABLET, COATED | 90 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 10542-009-09 | EA - Each | 10542-009 | 9a5d15ce-d1dd-4485-9c7d-78d8a958a6f6 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Alpha-Tocopherol Succinate, D- | ACTIVE INGREDIENT | LU4B53JYVE | 4 | |
| Ascorbic Acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 4 | |
| Biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 4 | |
| Calcium Pantothenate | ACTIVE INGREDIENT | 568ET80C3D | 4 | |
| Cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 4 | |
| Cobalamin | ACTIVE INGREDIENT | 8406EY2OQA | 4 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 4 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 4 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 4 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 4 | |
| Selenium | ACTIVE INGREDIENT | H6241UJ22B | 4 | |
| Thiamine Mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 4 | |
| Zinc Citrate | ACTIVE INGREDIENT | K72I3DEX9B | 4 | |
| Alpha-Tocopherol | ACTIVE MOIETY | H4N855PNZ1 | 4 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 4 | |
| Biotin | ACTIVE MOIETY | 6SO6U10H04 | 4 | |
| Cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 4 | |
| Cobalamin | ACTIVE MOIETY | 8406EY2OQA | 4 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 4 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 4 | |
| Pantothenic Acid | ACTIVE MOIETY | 19F5HK2737 | 4 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 4 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 4 | |
| Selenium | ACTIVE MOIETY | H6241UJ22B | 4 | |
| Thiamine | ACTIVE MOIETY | X66NSO3N35 | 4 | |
| Zinc | ACTIVE MOIETY | J41CSQ7QDS | 4 | |
| Calcium Stearate | INACTIVE INGREDIENT | 776XM7047L | 4 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 4 | |
| Croscarmellose Sodium | INACTIVE INGREDIENT | M28OL1HH48 | 4 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 4 | |
| Shellac | INACTIVE INGREDIENT | 46N107B71O | 4 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 4 | |
| Sodium Copper Chlorophyllin | INACTIVE INGREDIENT | 1D276TYV9O | 4 | |
| Starch, Corn | INACTIVE INGREDIENT | O8232NY3SJ | 4 |
Products#
Every source-derived product name is available through these pages.
- Dialyvite Supreme D
- Ascorbic Acid, Cholecalciferol, Alpha-Tocopherol, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium
- Ascorbic Acid
- Cholecalciferol
- .alpha.-tocopherol succinate, d-
- .alpha.-tocopherol, d-
- Thiamine Mononitrate
- Thiamine Ion
- Thiamine
- Riboflavin
- Niacinamide
- Pyridoxine Hydrochloride
- Pyridoxine
- Folic Acid
- Cobalamin
- Biotin
- Calcium Pantothenate
- Pantothenic Acid
- Zinc Citrate
- Zinc Cation
- Selenocysteine
- Selenium
- Microcrystalline Cellulose
- Croscarmellose Sodium
- Glyceryl Monostearate
- Shellac
- Starch, Corn
- Silicon Dioxide
- Calcium Stearate
- Sodium Copper Chlorophyllin
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10542-009 | 10542-009-09, 10542-009-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Starch, Corn | STARCH, CORN | O8232NY3SJ | TABLET, EXTENDED RELEASE / ORAL | 184 mg | ||
| Calcium Stearate | CALCIUM STEARATE | 776XM7047L | TABLET, CHEWABLE / ORAL | 240 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / OPHTHALMIC | 0.5 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Calcium Stearate | CALCIUM STEARATE | 776XM7047L | TABLET / BUCCAL | 1.42 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, DELAYED RELEASE / ORAL | 789.6 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | GRANULE / ORAL | 150 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | SUSPENSION/ DROPS / ORAL | 90 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | CAPSULE, EXTENDED RELEASE / ORAL | 194 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| Calcium Stearate | CALCIUM STEARATE | 776XM7047L | TABLET, FILM COATED / ORAL | 16 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | SUSPENSION / ORAL | 150 mg | ||
| Calcium Stearate | CALCIUM STEARATE | 776XM7047L | TABLET, ORALLY DISINTEGRATING / ORAL | 112 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 19 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, EXTENDED RELEASE / ORAL | 86 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, ORALLY DISINTEGRATING / ORAL | 184 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 21 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | DROPS / ORAL | NA | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Shellac | SHELLAC | 46N107B71O | CAPSULE, DELAYED RELEASE / ORAL | 1 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | SUSPENSION / ORAL | 900 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | TABLET / SUBLINGUAL | 409 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | CAPSULE, COATED PELLETS / ORAL | 198 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, EXTENDED RELEASE / ORAL | 529 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, CHEWABLE / ORAL | 216 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | CAPSULE, DELAYED RELEASE / ORAL | 216 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING / ORAL | 100 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | POWDER, FOR SUSPENSION / ORAL | 34 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | TABLET, CHEWABLE / ORAL | 180 mg | ||
| Shellac | SHELLAC | 46N107B71O | CAPSULE / ORAL | 34.48 mg | ||
| Starch, Corn | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| Calcium Stearate | CALCIUM STEARATE | 776XM7047L | TABLET / SUBLINGUAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e4c39ddd-ac1c-48f2-8251-6b6fe4f570a9 | 46fc3acf-1e6d-4830-ae9a-abd9c1132fca | 2026-01-27 | Adverse reactions | e4c39ddd-ac1c-48f2-8251-6b6fe4f570a9 46fc3acf-1e6d-4830-ae9a-abd9c1132fca |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.